Angiotech Triumphs In Stent Patent Appeal

Law360, New York (March 15, 2007, 12:00 AM EDT) -- Marking the latest triumph for Angiotech Pharmaceuticals Inc. in its bid to protect its drug-coated coronary stent patent throughout Europe, the company on Thursday said the European Patent Office in Munich, Germany has denied a bid for an appeal by two rival medical device makers.

Angiotech said in a statement on Thursday that the EPO’s Technical Board of Appeal had rejected an attempt by Conor Medsystems Inc. and Sahajanand Medical Technologies Pvt. Ltd. to intervene and appeal an earlier decision by the EPO’s Opposition Division which...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.